BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 2982949)

  • 1. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
    Fitzgerald PA; Mendelsohn M; Lopez C
    J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
    Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T
    J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
    Paya CV; McKean DJ; Segal DM; Schoon RA; Showalter SD; Leibson PJ
    J Immunol; 1989 Jan; 142(2):666-71. PubMed ID: 2536060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interferon in natural kill of HSV-1-infected fibroblasts.
    Fitzgerald PA; von Wussow P; Lopez C
    J Immunol; 1982 Aug; 129(2):819-23. PubMed ID: 6177785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interferon in human natural killer activity against target cells infected with HSV-1.
    Bishop GA; Glorioso JC; Schwartz SA
    J Immunol; 1983 Oct; 131(4):1849-53. PubMed ID: 6194217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.
    Paya CV; Schoon RA; Leibson PJ
    J Immunol; 1990 Jun; 144(11):4370-5. PubMed ID: 2160501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human newborn natural killer cell responses to activation by monoclonal antibodies. Effect of culture with herpes simplex virus.
    Hayward A; Laszlo M; Vafai A
    J Immunol; 1989 Feb; 142(4):1139-43. PubMed ID: 2536766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
    Muñoz A; Carrasco L; Fresno M
    J Immunol; 1983 Aug; 131(2):783-7. PubMed ID: 6190939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
    Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
    J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF; Welsh RM
    J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
    Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
    J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
    Klimpel GR; Asuncion M; Fons M; Norton JD; Albrecht T; Klimpel KD; Stein MD
    J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.
    Borysiewicz LK; Rodgers B; Morris S; Graham S; Sissons JG
    J Immunol; 1985 Apr; 134(4):2695-701. PubMed ID: 2579152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell.
    Braun RW; Teute HK; Kirchner H; Munk K
    J Immunol; 1984 Feb; 132(2):914-9. PubMed ID: 6317753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of herpes simplex virus on induced cell-mediated cytotoxicity in neonates and adults.
    Chin TW; Plaeger-Marshall S; Ank BJ; Pressman SR; Stiehm ER
    Nat Immun Cell Growth Regul; 1991; 10(5):237-46. PubMed ID: 1661847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
    Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW
    Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically.
    Pietra G; Semino C; Cagnoni F; Boni L; Cangemi G; Frumento G; Melioli G
    J Med Virol; 2000 Nov; 62(3):354-63. PubMed ID: 11055246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.